Orchid Pharma Share Price
Start SIP in Orchid Pharma
Start SIPOrchid Pharma Performance
Day Range
- Low 1,426
- High 1,484
52 Week Range
- Low 432
- High 1,590
- Open Price1,484
- Previous Close1,480
- Volume97810
Orchid Pharma Investment Rating
-
Master Rating:
-
Orchid Pharma has an operating revenue of Rs. 880.85 Cr. on a trailing 12-month basis. Pre-tax margin of 11% is healthy, ROE of 7% is fair but needs improvement. The company has a reasonable debt to equity of 10%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 12% and 80% from 50DMA and 200DMA. It has recently broken out of a base in its weekly chart and is trading around 8% from the pivot point (which is extended from the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 39 which is a POOR score indicating inconsistency in earnings, a RS Rating of 86 which is GOOD indicating the outperformance as compared to other stocks, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 46 indicates it belongs to a fair industry group of Medical-Diversified and a Master Score of B is close to being the best. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock is lagging behind in earnings parameter, but excellent technical strength makes it a stock to examine in more detail.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
|---|---|---|---|---|---|---|
| Oper Rev Qtr Cr | 244 | 217 | 221 | 199 | 183 | 210 |
| Operating Expenses Qtr Cr | 211 | 188 | 185 | 175 | 161 | 170 |
| Operating Profit Qtr Cr | 33 | 29 | 36 | 24 | 22 | 40 |
| Depreciation Qtr Cr | 8 | 8 | 9 | 8 | 8 | 7 |
| Interest Qtr Cr | 3 | 3 | 4 | 4 | 6 | 7 |
| Tax Qtr Cr | 0 | -3 | 0 | 0 | 0 | 0 |
| Net Profit Qtr Cr | 29 | 33 | 31 | 20 | 11 | 65 |
Orchid Pharma Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 7
- Bearish Moving Average
- ___
- 9
- 20 Day
- ₹1,454.12
- 50 Day
- ₹1,376.41
- 100 Day
- ₹1,264.77
- 200 Day
- ₹1,092.53
- 20 Day
- ₹1,445.24
- 50 Day
- ₹1,377.73
- 100 Day
- ₹1,227.22
- 200 Day
- ₹1,067.00
Orchid Pharma Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 1,471.77 |
| Second Resistance | 1,506.38 |
| Third Resistance | 1,529.27 |
| RSI | 50.05 |
| MFI | 65.78 |
| MACD Single Line | 35.63 |
| MACD | 32.56 |
| Support | |
|---|---|
| First Support | 1,414.27 |
| Second Support | 1,391.38 |
| Third Supoort | 1,356.77 |
Orchid Pharma Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 102,660 | 5,332,160 | 51.94 |
| Week | 71,504 | 3,668,176 | 51.3 |
| 1 Month | 101,701 | 5,083,039 | 49.98 |
| 6 Month | 131,783 | 7,508,978 | 56.98 |
Orchid Pharma Result Highlights
Orchid Pharma Synopsis
NSE-Medical-Diversified
Orchid Pharma is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 819.37 Cr. and Equity Capital is Rs. 50.72 Cr. for the Year ended 31/03/2024. Orchid Pharma Ltd. is a Public Limited Listed company incorporated on 01/07/1992 and has its registered office in the State of Tamil Nadu, India. Company’s Corporate Identification Number(CIN) is L24222TN1992PLC022994 and registration number is 022994.| Market Cap | 7,506 |
| Sales | 881 |
| Shares in Float | 1.52 |
| No of funds | 64 |
| Yield |
| Book Value | 6.16 |
| U/D Vol ratio | 2.2 |
| LTDebt / Equity | 10 |
| Alpha | 0.61 |
| Beta | 0.52 |
Orchid Pharma Shareholding Pattern
| Owner Name | Jun-24 | Mar-24 | Dec-23 | Sep-23 |
|---|---|---|---|---|
| Promoters | 69.84% | 69.84% | 69.84% | 72.4% |
| Mutual Funds | 16.91% | 15.18% | 10.4% | 9.76% |
| Insurance Companies | 0.87% | 0.94% | 2.45% | |
| Foreign Portfolio Investors | 1.42% | 1.96% | 4.14% | 8.08% |
| Financial Institutions/ Banks | 0.11% | 0.11% | 0.12% | 0.12% |
| Individual Investors | 7.16% | 7.44% | 7.79% | 3.85% |
| Others | 3.69% | 4.53% | 5.26% | 5.79% |
Orchid Pharma Management
| Name | Designation |
|---|---|
| Mr. Ram Gopal Agarwal | Chairman & Non-Exe.Director |
| Mr. Manish Dhanuka | Managing Director |
| Mr. Mridul Dhanuka | Whole Time Director |
| Mr. Arjun Dhanuka | Non Executive Director |
| Mrs. Tanu Singla | Independent Director |
| Dr. Dharam Vir | Independent Director |
| Mr. Manoj Kumar Goyal | Independent Director |
| Ms. Shubha Singh | Independent Director |
Orchid Pharma Forecast
Price Estimates
Orchid Pharma Corporate Action
| Date | Purpose | Remarks |
|---|---|---|
| 2024-08-12 | Quarterly Results | |
| 2024-05-23 | Audited Results | |
| 2024-02-08 | Quarterly Results | |
| 2023-11-04 | Quarterly Results | |
| 2023-08-10 | Quarterly Results |
Orchid Pharma FAQs
What is Share Price of Orchid Pharma ?
Orchid Pharma share price is ₹1,437 As on 18 September, 2024 | 02:25
What is the Market Cap of Orchid Pharma ?
The Market Cap of Orchid Pharma is ₹7289.1 Cr As on 18 September, 2024 | 02:25
What is the P/E ratio of Orchid Pharma ?
The P/E ratio of Orchid Pharma is 65.3 As on 18 September, 2024 | 02:25
What is the PB ratio of Orchid Pharma ?
The PB ratio of Orchid Pharma is 6.2 As on 18 September, 2024 | 02:25